Current and emerging therapies for advanced biliary tract cancers
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference108 articles.
1. Biliary tract cancers: current knowledge, clinical candidates and future challenges;Tariq;Cancer Manag Res,2019
2. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis;Clements;J Hepatol,2020
3. Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise;Saha;Oncologist,2016
4. Cholangiocarcinoma–evolving concepts and therapeutic strategies;Rizvi;Nat Rev Clin Oncol,2018
5. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations;Wardell;J Hepatol,2018
Cited by 76 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Non-coding RNA and Drug resistance in cholangiocarcinoma;Non-coding RNA Research;2024-03
2. Immunotherapy and targeted therapy for cholangiocarcinoma: Artificial intelligence research in imaging;Critical Reviews in Oncology/Hematology;2024-02
3. PP4R1 promotes glycolysis and gallbladder cancer progression through facilitating ERK1/2 mediated PKM2 nuclear translocation;Cancer Letters;2024-02
4. Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma;Nature Communications;2024-01-20
5. A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer;Clinical & Translational Immunology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3